| dc.contributor | Grossmann, Martin U. | en_US |
| dc.contributor | Sloan School of Management. | en_US |
| dc.date.accessioned | 2003-04-29T05:16:27Z | |
| dc.date.available | 2003-04-29T05:16:27Z | |
| dc.date.issued | 1998 | en_US |
| dc.identifier.uri | http://hdl.handle.net/1721.1/2713 | |
| dc.description | Title from cover. "May, 1998." "#4020-98-MSA" | en_US |
| dc.description | Includes bibliographical references (p. 41-43). | en_US |
| dc.description.statementofresponsibility | Martin U. Grossmann. | en_US |
| dc.format.extent | 43 p. | en_US |
| dc.format.extent | 2995253 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | eng | en_US |
| dc.publisher | Sloan School of Management, Massachusetts Institute of Technology | en_US |
| dc.relation.ispartofseries | Working paper (Sloan School of Management) ; WP 4020-98. | en_US |
| dc.subject.lcc | HD28 .M414 no.4020-98 | en_US |
| dc.title | Growth policies for biopharmaceutical companies : a dynamic problem definition | en_US |
